輸入代號或公司名稱後按 Enter
6130

上亞科技

-0.70 (-2.85%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
23.9089成交張數本益比1.88股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.28-1.020.1224.4%2.16%-7.76%
2026Q1-0.31-1.65-0.14-34.5%-2.52%-12.82%
2025Q4-0.66-1.72-0.29-79.1%-5.26%-13.04%
2025Q3-0.33-1.72-0.15-37.8%-2.55%-12.42%
2025Q2-0.35-488.9%-1.44-0.15-39.9%-2.57%-10.21%
2025Q1-0.38-1.00-0.17-42.1%-2.70%-6.92%
2024Q4-0.66-0.75-0.29-69.5%-4.58%-5.11%
2024Q3-0.05-200.0%-2.58-0.02-4.2%-0.35%-15.75%
2024Q20.09-89.3%-2.480.046.3%0.57%-15.08%
2024Q1-0.13-1.73-0.06-15.0%-0.82%-10.61%
2023Q4-2.49-529.3%-1.81-1.10-206.4%-14.92%-11.01%
2023Q30.05-44.4%1.260.023.5%0.27%7.06%
2023Q20.841.300.3757.9%4.76%7.12%
2023Q1-0.210.15-0.09-17.2%-1.19%0.76%
2022Q40.5848.7%0.030.24129.9%3.20%0.21%
2022Q30.09-76.3%-0.160.039.2%0.34%-1.94%
2022Q2-0.31-175.1%0.13-0.13-60.3%-2.16%-0.41%
2022Q1-0.330.85-0.13-72.8%-2.69%6.46%
2021Q40.391.060.1355.4%3.31%8.60%
2021Q30.380.370.1145.0%3.58%3.48%
2021Q20.41-0.250.1337.1%4.57%-2.75%
2021Q1-0.12-0.90-0.04-18.0%-1.41%-9.80%
2020Q4-0.30-0.86-0.09-25.4%-3.31%-10.01%
2020Q3-0.24-0.63-0.08-22.3%-2.64%-7.16%
2020Q2-0.23-0.62-0.07-17.6%-2.47%-6.18%
2020Q1-0.08-0.50-0.03-10.3%-0.96%-4.62%
2019Q4-0.07-0.57-0.02-8.0%-0.78%-5.71%
2019Q3-0.23-0.97-0.05-42.7%-1.91%-9.67%
2019Q2-0.11-0.94-0.03-35.2%-1.29%-10.07%
2019Q1-0.16-0.94-0.05-25.4%-1.77%-9.92%
2018Q4-0.46-0.83-0.13-121.6%-4.86%-8.63%
2018Q3-0.21-0.42-0.06-50.8%-2.18%-4.29%
2018Q2-0.11-0.44-0.03-25.5%-1.15%-4.34%
2018Q1-0.05-0.38-0.01-6.9%-0.45%-3.70%
2017Q4-0.06-130.0%-0.37-0.01-7.2%-0.51%-3.56%
2017Q3-0.23-0.12-0.06-32.1%-2.23%-1.19%
2017Q2-0.060.08-0.02-7.0%-0.52%0.74%
2017Q1-0.03-130.0%-0.05-0.01-3.9%-0.32%-0.43%
2016Q40.190.080.0514.2%1.86%
2016Q3-0.03-0.01-2.3%-0.29%